A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients
Clinical trial NCT04604782 · RECRUITING
Trial details
- NCT number
- NCT04604782
- Sponsor
- GE Healthcare
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-20
- Primary completion
- 2026-12-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.